49
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A Rabbit Dry Eye Model Induced by Subcutaneous Scopolamine

, , , &
Received 11 Dec 2023, Accepted 23 Apr 2024, Published online: 08 May 2024

References

  • Tsubota K, Yokoi N, Shimazaki J, Watanabe H, Dogru M, Yamada M, Kinoshita S, Kim H-M, Tchah H-W, Hyon JY, et al. New perspectives on dry eye definition and diagnosis: a consensus report by the Asia Dry Eye Society. Ocul Surf. 2017;15(1):65–76. doi: 10.1016/j.jtos.2016.09.003.
  • Lemp MA. Report of the national eye institute/industry workshop on clinical trials in dry eyes. Clao J. 1995;21(4):221–232.
  • Lemp MA. Recent developments in dry eye management. Ophthalmology. 1987;94(10):1299–1304. doi: 10.1016/s0161-6420(87)80015-5.
  • Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo C-K, Liu Z, Nelson JD, Nichols JJ, Tsubota K, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283. doi: 10.1016/j.jtos.2017.05.008.
  • Tsubota K, Yokoi N, Watanabe H, Dogru M, Kojima T, Yamada M, Kinoshita S, Kim H-M, Tchah H-W, Hyon JY, et al. A new perspective on dry eye classification: proposal by the Asia Dry Eye Society. Eye Contact Lens. 2020;46 Suppl 1(1):S2–S13. doi: 10.1097/ICL.0000000000000643.
  • Qin DY, Wang LX, Deng YP. Transgenic dry eye mouse models: powerful tools to study dry eye disease. Int J Ophthalmol. 2022;15(4):635–645. doi: 10.18240/ijo.2022.04.18.
  • Dursun D, Wang M, Monroy D, Li DQ, Lokeshwar BL, Stern ME, Pflugfelder SC. A mouse model of keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci. 2002;43(3):632–638.
  • Viau S, Maire M-A, Pasquis B, Grégoire S, Fourgeux C, Acar N, Bretillon L, Creuzot-Garcher CP, Joffre C. Time course of ocular surface and lacrimal gland changes in a new scopolamine-induced dry eye model. Graefes Arch Clin Exp Ophthalmol. 2008;246(6):857–867. doi: 10.1007/s00417-008-0784-9.
  • Xiao B, Wang Y, Reinach PS, Ren Y, Li J, Hua S, Lu H, Chen W. Dynamic ocular surface and lacrimal gland changes induced in experimental murine dry eye. PLoS One. 2015;10(1):e0115333. doi: 10.1371/journal.pone.0115333.
  • Yang F-M, Fan D, Yang X-Q, Zhu F-H, Shao M-J, Li Q, Liu Y-T, Lin Z-M, Cao S-Q, Tang W, et al. The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4/NF-kappaB/NLRP3 signaling. Acta Pharmacol Sin. 2021;42(4):593–603. doi: 10.1038/s41401-020-0484-5.
  • Chen Y, Pu J, Li X, Lian L, Ge C, Liu Z, Wang W, Hou L, Chen W, Li J. Aim2 deficiency ameliorates lacrimal gland destruction and corneal epithelium defects in an experimental dry eye model. Invest Ophthalmol Vis Sci. 2023;64(3):26. doi: 10.1167/iovs.64.3.26.
  • Honkanen R, Huang W, Huang L, Kaplowitz K, Weissbart S, Rigas B. A new rabbit model of chronic dry eye disease induced by complete surgical dacryoadenectomy. Curr Eye Res. 2019;44(8):863–872. doi: 10.1080/02713683.2019.1594933.
  • Zernii EY, Baksheeva VE, Iomdina EN, Averina OA, Permyakov SE, Philippov PP, Zamyatnin AA, Senin II. Rabbit models of ocular diseases: new relevance for classical approaches. CNS Neurol Disord Drug Targets. 2016;15(3):267–291. doi: 10.2174/1871527315666151110124957.
  • Qiu J-, Y JJ, Zhou S-Y, Liu F, Chen J-Q. An experimental of rabbit tear-deficient dry eye model by subcutaneous injection of scopolamine hydrobromide. Ophthalmol Chin. 2009;18(6):404–409.
  • Hodges RR, Dartt DA. Regulatory pathways in lacrimal gland epithelium. Int Rev Cytol. 2003;231:129–196. doi: 10.1016/s0074-7696(03)31004-6.
  • Bacman S, Perez Leiros C, Sterin-Borda L, Hubscher O, Arana R, Borda E. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjogren’s syndrome. Invest Ophthalmol Vis Sci. 1998;39(1):151–156.
  • Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren’s syndrome. Arthritis Rheum. 2000;43(7):1647–1654. doi: 10.1002/1529-0131(200007)43:7<1647::AID-ANR31>3.0.CO;2-P.
  • Matsui M, Motomura D, Karasawa H, Fujikawa T, Jiang J, Komiya Y, Takahashi S, Taketo MM. Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci USA. 2000;97(17):9579–9584. doi: 10.1073/pnas.97.17.9579.
  • Davis FA. The anatomy and histology of the eye and orbit of the rabbit. Trans Am Ophthalmol Soc. 1929;27:400 2–441.
  • Xiong C, Chen D, Liu J, Liu B, Li N, Zhou Y, Liang X, Ma P, Ye C, Ge J, et al. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride. Invest Ophthalmol Vis Sci. 2008;49(5):1850–1856. doi: 10.1167/iovs.07-0720.
  • Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22(7):640–650. doi: 10.1097/00003226-200310000-00008.
  • Lin BW, Chen MZ, Fan SX, Chuck RS, Zhou SY. Effect of 0.025% FK-506 eyedrops on botulinum toxin B-induced mouse dry eye. Invest Ophthalmol Vis Sci. 2014;56(1):45–53. doi: 10.1167/iovs.13-12925.
  • Argüeso P, Balaram M, Spurr-Michaud S, Keutmann HT, Dana MR, Gipson IK. Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjogren syndrome. Invest Ophthalmol Vis Sci. 2002;43(4):1004–1011.
  • Johnson ME, Murphy PJ. Changes in the tear film and ocular surface from dry eye syndrome. Prog Retin Eye Res. 2004;23(4):449–474. doi: 10.1016/j.preteyeres.2004.04.003.
  • Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci. 2000;41(6):1356–1363.
  • Zhao H, Jumblatt JE, Wood TO, Jumblatt MM. Quantification of MUC5AC protein in human tears. Cornea. 2001;20(8):873–877. doi: 10.1097/00003226-200111000-00019.
  • McKenzie RW, Jumblatt JE, Jumblatt MM. Quantification of MUC2 and MUC5AC transcripts in human conjunctiva. Invest Ophthalmol Vis Sci. 2000;41(3):703–708.
  • Fan NW, Dohlman TH, Foulsham W, McSoley M, Singh RB, Chen Y, Dana R. The role of Th17 immunity in chronic ocular surface disorders. Ocul Surf. 2021;19:157–168. doi: 10.1016/j.jtos.2020.05.009.
  • Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42(10):2283–2292.
  • Yoon KC, Jeong IY, Park YG, Yang SY. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea. 2007;26(4):431–437. doi: 10.1097/ICO.0b013e31803dcda2.
  • Lam H, Bleiden L, de Paiva CS, Farley W, Stern ME, Pflugfelder SC. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009;147(2):198–205 e1. doi: 10.1016/j.ajo.2008.08.032.
  • Pflugfelder SC. Anti-inflammatory therapy of dry eye. Ocul Surf. 2003;1(1):31–36. doi: 10.1016/s1542-0124(12)70005-8.
  • Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology. 2000;107(4):631–639. doi: 10.1016/s0161-6420(99)00176-1.
  • Eickholz P, Kim T-S, Bürklin T, Schacher B, Renggli HH, Schaecken MT, Holle R, Kübler A, Ratka-Krüger P. Non-surgical periodontal therapy with adjunctive topical doxycycline: a double-blind randomized controlled multicenter study. J Clin Periodontol. 2002;29(2):108–117. doi: 10.1034/j.1600-051x.2002.290204.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.